Table 5.
Resilience in relation to sleep, anxiety, somatization, and quality of life
| Assessment | n | Crude β (95% CI) | Adjusteda β (95% CI) |
| Somatic symptoms (CSSI) | 35 | −0.21 (−0.41 to −0.002) | −0.20 (−0.40 to 0.01) |
| Pediatric sleep Q (PSQ) | 35 | −9.68 (−25.53 to 6.17) | −11.34 (−27.12 to 4.51) |
| Anxiety (STAI-C state) | 35 | −0.68 (−1.02 to −0.33) | −0.66 (−1.01 to −0.32) |
| Anxiety (STAI-C trait) | 35 | −0.45 (−0.68 to −0.22) | −0.44 (−0.67 to −0.21) |
| EoE symptoms (PEESSv2.0) | 34 | −0.09 (−0.24 to 0.05) | −0.07 (−0.22 to 0.07) |
| Quality of life (PedsQL) | 35 | 0.10 (−0.07 to 0.27) | 0.09 (−0.09 to 0.26) |
CI, confidence interval; CSSI-24, Child Somatic Symptoms Inventory 24; PEESSv2.0, Pediatric Eosinophilic Esophagitis Symptom Score version 2.0; PSQ, Pediatric Sleep Questionnaire; STAI-C, State-Trait Anxiety Score for Children.
a
Adjusted for disease duration since diagnosis.